Notice of Intent to Sole Source a Blanket Purchase Agreement (BPA) for a variety of radiopharmaceuticals (radiology medications) for use in the Nuclear Medicine Division at Naval Medical Center San Diego
ID: HT941024N0136Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYFALLS CHURCH, VA, 22042, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/ab197db932f64d57bf684a787aac8f8b/view
Timeline
    Description

    The Department of Defense, through the Defense Health Agency (DHA), intends to award a sole source Blanket Purchase Agreement (BPA) to RLS (USA), Inc. for the procurement of various radiopharmaceuticals required by the Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD). This five-year contract will cover the supply of 31 essential radiopharmaceuticals, four additional medications, and expedited delivery services, all of which are critical for diagnostic imaging and treatment in Nuclear Medicine. Due to the radioactive nature and short shelf-life of these medications, strict adherence to transportation regulations is necessary, with deliveries occurring daily. Interested vendors may submit capability statements by September 10, 2024, to Jennifer Collins at jennifer.e.collins23.civ@health.mil, as this opportunity does not involve competitive proposals.

    Files
    Title
    Posted
    HT941024N0136 NOI.pdf
    The Notice of Intent to Sole Source HT941024N0136 outlines the Defense Health Agency's (DHA) plan to award a five-year Blanket Purchase Agreement (BPA) to RLS (USA), Inc. for the procurement of various radiopharmaceuticals needed at Naval Medical Center San Diego (NMCSD). This sole source award is justified under the Federal Acquisition Regulation's provisions, as RLS is deemed the only provider capable of fulfilling the specific requirements for 31 essential radiopharmaceuticals, four additional medications, and expedited delivery services. Radiopharmaceuticals are crucial for diagnostic imaging and treatments in Nuclear Medicine, warranting strict adherence to transportation regulations due to their radioactive properties and short shelf-life. The BPA is set to be effective from October 1, 2024, to September 30, 2029. Interested parties may submit capability statements by the specified deadline; however, initial competitive proposals are not solicited, as the decision to proceed with a sole source contract rests solely with the government. The document emphasizes the serious nature of the contract and the limited timeframe for vendors to present their qualifications, reflecting standard government RFP practices focused on efficiency and compliance within sensitive health sectors.
    Similar Opportunities
    6505--PET MRI Radiopharmaceuticals
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to enter into a sole source procurement for PET MRI Radiopharmaceuticals for the John D. Dingell VA Medical Center in Detroit, MI. This contract will provide essential radiopharmaceuticals necessary for conducting nuclear medicine exams on PET MRI patients, with a one-year purchase order scheduled from October 1, 2024, to September 30, 2025. The procurement includes specific products such as Cu64 Dotatate, F18 PSMA, F18 FDG, and F18 Vizamyl, with estimated annual quantities outlined in the opportunity. Interested parties may express their interest and demonstrate their capability to meet the requirements by the deadline of September 17, 2024, by contacting Contracting Officer Jeffrey Rozema at jeffrey.rozema@va.gov.
    6505--Pylarify(Piflufolastat F18 Injection) for DC VAMC
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified sources to provide Pylarify (Piflufolastat F18 Injection) for the DC Veterans Affairs Medical Center (DC VAMC) in Washington, D.C. The procurement involves the delivery of this radiopharmaceutical to the Nuclear Medicine Section of the Radiology Service, with a base contract period of one year and four optional one-year extensions. This product is critical for diagnostic imaging and treatment in nuclear medicine, and the contractor must ensure compliance with various regulatory standards while providing online ordering capabilities and timely deliveries. Interested parties should submit their responses, including company information and capabilities, to Ryan Singletary at Ryan.Singletary@va.gov by September 16, 2024, at 3:00 PM EST.
    Medrad Injection and Infusion Systems Services and Maintenances
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is seeking qualified small businesses to provide maintenance services for ten government-owned Medrad injection and infusion systems at the Naval Medical Center San Diego. The procurement aims to ensure comprehensive service and preventive maintenance, adhering to OEM specifications and regulatory standards, with a focus on maintaining a minimum uptime rate of 95% and conducting preventive maintenance at least twice a year. This contract is crucial for the operational efficiency of medical equipment used in healthcare settings, reflecting the government's commitment to reliable medical services. Interested vendors must submit their proposals electronically by September 13, 2024, with a budget cap of $34 million for the base year, which runs from September 20, 2024, to September 19, 2025. For further inquiries, contact Dania Suazo at dania.suazo.civ@health.mil or call 619-453-9951.
    Pharmaceutical Preparation Manufacturing
    Active
    Dept Of Defense
    Sources Sought DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking local sources capable and interested in fulfilling a requirement for the procurement and delivery of CLASS VIII, Medical Laboratory Reagents, in support of United States Naval Hospital (USNH), located in Okinawa, Japan. The procurement is for ULTRA TECHNE KOW 18.5GBq Injection Generator, with an estimated quantity of 26 units per year. The delivery location will be the United States Naval Hospital (USNH) Okinawa Nuclear Medicine Department, Camp Foster, Okinawa, Japan. Interested parties should provide company information, capability to provide the items, and item lead times. Responses must be submitted by Thursday, November 09, 2023, via email to jasielle.castro@dla.mil and mamiko.jackson@dla.mil.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense (DoD) is issuing a Request for Quotation (RFQ) for the establishment of Blanket Purchase Agreements (BPA) and Additional Discount Program (ADP) agreements related to pharmaceutical agents under the Defense Health Agency's Uniform Formulary (UF). This procurement aims to secure pricing agreements for various newly approved drugs, including those in the classes of Parkinson's agents, gastrointestinal agents, respiratory agents, hematological agents, targeted immunomodulatory biologics, anticonvulsants, and oncological agents, which will be reviewed during the Pharmacy and Therapeutics (P&T) Committee meeting scheduled for November 6-7, 2024. The initiative is crucial for maintaining an effective pharmacy benefits program for the Military Health System (MHS), ensuring that military personnel have access to high-value medications while adhering to cost-effectiveness criteria. Interested manufacturers must submit their quotes by September 19, 2024, and can direct inquiries to primary contact Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil or secondary contact Tracy Banks at tracy.e.banks2.civ@health.mil.
    Piflufolastat F-18 injection drugs (Pylarify) from Sofie Co. (Notice of Intent to sole source)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole-source contract with Sofie Co. for the procurement of Piflufolastat F-18 injection drugs (Pylarify) essential for clinical nuclear medicine procedures at the NIH Clinical Center. This acquisition aims to secure compounded, patient-ready doses of the radiopharmaceutical, which is critical for diagnosing and treating diseases in accordance with patient care protocols. The drugs are FDA-approved and must be compounded and delivered on a time-sensitive basis due to their rapid radiation decay, making Sofie Co. the only authorized provider capable of meeting these specialized requirements. Interested parties may submit capability statements by September 18, 2024, to Lu Chang at lu-chang.lu@nih.gov, as this is not a request for proposals.
    Maintenance for fMRI software
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract to Nordic Neuro Lab, Inc. for maintenance services related to the existing NordicBrain software and hardware at Walter Reed National Military Medical Center (WRNMMC) in Bethesda, Maryland. This procurement aims to ensure ongoing support and maintenance of specialized medical software and hardware that are critical for the operations of the Radiology Department at WRNMMC. The contract will be awarded under the authority permitting Other than Full and Open Competition, with interested parties required to express their capabilities by 10:00 AM EST on September 19, 2024, via email to the primary contact, Ealed Nuru, at ealed.m.nuru.civ@health.mil, with a copy to Erica S. Oh at erica.s.oh.civ@health.mil.
    One-Time Corrective Maintenance of one (1) Acutemp Thermal Pallette Refrigeration System
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source service contract to CSafe Global for the one-time corrective maintenance of an Acutemp Thermal Pallette Refrigeration System at the Naval Medical Center San Diego (NMCSD). This contract aims to ensure the reliable operation of the refrigeration system in accordance with manufacturer specifications, following the guidelines set forth by the Federal Acquisition Regulation (FAR) for sole source procurement. The maintenance services are scheduled to take place from September 30, 2024, to October 30, 2024, with interested vendors required to submit capability statements by September 16, 2024, to the primary contact, Danielle M Zulfer, at danielle.m.zulfer.civ@health.mil. No competitive proposals will be accepted, and all inquiries must be submitted via email.
    American College of Radiology
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to make a Sole Source Award to the American College of Radiology (ACR) for the accreditation of multiple mammography units. This procurement involves the first unit fees for Mammography Units 11, 12, 13, and 14, each requiring two modules for accreditation. The services are critical for ensuring compliance with health standards and maintaining the quality of radiological services provided to military personnel. Interested parties can reach out to Luis Zeno at luis.a.zeno-pimentel.civ@health.mil or call 757-953-6084 for further details, as the award will be made following the close of the posting period.
    BPA - X-RAY FILM AND SUPPLIES PSC 6525
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Navy's Naval Surface Warfare Center Indian Head Division, has issued a Combined Synopsis/Solicitation notice for the procurement of X-ray film and supplies. These supplies are typically used in medical, dental, and veterinary imaging equipment. The procurement will be a Total Small Business Set-Aside and the place of performance is Indian Head, Maryland. The notice includes a list of specific items that will be procured, such as radiographic film and radiographic processing chemicals. Interested companies must provide documentation addressing their capabilities and expertise, as well as a price list if applicable. Blanket Purchase Agreements (BPAs) will be awarded based on positive Past Performance, and interested vendors should provide a minimum of three Past Performance References. The government reserves the right to use additional references if available. Vendors should also have an active account in the Procurement Integrated Enterprise Environment (PIEE) and the System for Award Management (SAM). The government intends to issue Master BPAs on a 6-month rotation through February 2029. Interested vendors should submit documentation and references by email to Barbara.j.grinder.civ@us.navy.mil. The Points of Contact for this procurement are Barbara Grinder and Brandi Sorzano.